Mylan, Revance link to develop Botox biosimilar

2nd March 2018 Uncategorised 0

Mylan and Revance Therapeutics have unveiled plans to develop a biosimilar to Allergan’s neuromodulator Botox.

More: Mylan, Revance link to develop Botox biosimilar
Source: News